Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02820038 · ClinicalTrials.gov registry record · NA

Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management

A NA study of Rheumatoid Arthritis, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
286
Enrollment target
1
Study location

NCT02820038: Completed NA study of Rheumatoid Arthritis, sponsored by University of North Carolina, Chapel Hill.

NCT02820038 is a NA study of Rheumatoid Arthritis that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 286 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02820038, a NA study of Rheumatoid Arthritis, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
286 participants
Enrollment target
1
Study location

Study Summary

The aim of the proposed project is to compare the effectiveness of two strategies designed to enhance patient understanding of medication risks/benefits: (1) Medication Guides, mandated for many medications by the Food and Drug Administration and (2) Drug Facts Boxes, developed by Woloshin and Schwartz to enhance the usability of consumer medication information. The investigators will also assess whether the effectiveness of these communication strategies can be increased by Gist Reasoning Training, which is designed to enhance patients' ability to extract meaningful gist from complex information.The investigators anticipate enrolling 300 individuals with rheumatoid arthritis. The study will use a randomized controlled trial design with four study arms. Data will be collected primarily via self-administered, Internet-based surveys using REDCap. All participants will be followed for 6 months after the completion of baseline data collection.

Primary Outcome

Informed decision making is characterized by making a value-consistent decision based on accurate knowledge. Knowledge will be assessed as described under Outcome 2. Values will be assessed using a 10-item scale developed by Fraenkel et al. Scores on this scale can range from 0 to 10, with lower scores reflecting a reluctance to use medications to control disease activity. Participants will be classified as having made an informed choice if they: (1) answered at least 85% of the knowledge items

Conditions Studied

Interventions

  • BEHAVIORAL Medication Guides
  • BEHAVIORAL SMART Program
  • BEHAVIORAL Drug Facts Boxes

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 286 participants
Start Date 2016-09
Est. Completion 2018-12-31
Phase NA

What the finished NCT02820038 record still lists

NCT02820038 is an interventional study that assigns participants to a tested intervention. The registered 286 participants enrollment target is mid-sized for trials with a published cap, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 3 interventions - of which Medication Guides is the first listed.

NCT02820038 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02820038 about?

NCT02820038 is a clinical study titled "Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management". The aim of the proposed project is to compare the effectiveness of two strategies designed to enhance patient understanding of medication risks/benefits: (1) Medication Guides, mandated for many medications by the Food and Drug Administration and (2) Drug Facts Boxes, developed by Woloshin and Schwa...

What is the current status of trial NCT02820038?

This trial is currently completed. It is a NA study. The enrollment target is 286 participants. The study started on 2016-09. Estimated completion is 2018-12-31.

What conditions does trial NCT02820038 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT02820038?

The interventions under investigation include: Medication Guides (BEHAVIORAL), SMART Program (BEHAVIORAL), Drug Facts Boxes (BEHAVIORAL).

Who is sponsoring clinical trial NCT02820038?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02820038 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02820038's enrollment target sits among peer trials

286 62nd of 197 higher than 136 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04781140 · 286 participants · Phase 4

    Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

  • NCT04936529 · 286 participants · Phase 2

    A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

  • NCT05183646 · 286 participants · Phase 3

    A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

  • NCT05506878 · 286 participants · NA

    Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02820038, the US trial registry maintained by the National Library of Medicine. NCT02820038 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.